Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Burning Rock Biotech (BNR) Intangibles: 2019-2025

Historic Intangibles for Burning Rock Biotech (BNR) over the last 4 years, with Sep 2025 value amounting to $44,000.

  • Burning Rock Biotech's Intangibles fell 41.33% to $44,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $44,000, marking a year-over-year decrease of 41.33%. This contributed to the annual value of $58,000 for FY2024, which is 57.35% down from last year.
  • According to the latest figures from Q3 2025, Burning Rock Biotech's Intangibles is $44,000, which was down 88.60% from $386,000 recorded in Q1 2025.
  • In the past 5 years, Burning Rock Biotech's Intangibles registered a high of $2.8 million during Q3 2022, and its lowest value of $44,000 during Q3 2025.
  • Moreover, its 3-year median value for Intangibles was $119,500 (2023), whereas its average is $508,400.
  • Its Intangibles has fluctuated over the past 5 years, first skyrocketed by 322.22% in 2022, then tumbled by 94.13% in 2024.
  • Over the past 5 years, Burning Rock Biotech's Intangibles (Quarterly) stood at $808,000 in 2021, then tumbled by 64.36% to $288,000 in 2022, then crashed by 52.78% to $136,000 in 2023, then tumbled by 57.35% to $58,000 in 2024, then tumbled by 41.33% to $44,000 in 2025.
  • Its Intangibles was $44,000 in Q3 2025, compared to $386,000 in Q1 2025 and $58,000 in Q4 2024.